About CRI

Jun Tang, Ph.D.

Jun Tang

Senior Research Analyst

(212) 688-7515 x228
jtang@cancerresearch.org

Jun joined the Cancer Research Institute in January 2017 as a senior research analyst in the Institute’s Clinical Accelerator program, where he is using his scientific training to help accelerate the translation of new cancer immunotherapy combinations from labs to the clinic.

Prior to CRI, Jun spent more than a decade as a scientist in immunology and biomedical engineering. He received his bachelor degree in bioengineering in 2005 and a master degree in biochemistry in 2008 in China. After that, he moved to the U.S. and received his Ph.D. in 2014 from Icahn School of Medicine at Mount Sinai, where he developed nanomaterial-based immunotherapies for cardiovascular diseases and cancer. He then pursued a postdoctoral fellowship at Memorial Sloan Kettering Cancer Center in 2015, where he developed cancer immunotherapies for solid tumors and imaging probes for nuclear oncological imaging. Jun has published more than 20 peer-reviewed papers, given over ten conference presentations, won eight research awards, and filed one patent.

Jun strongly believes that cancer immunotherapy will revolutionize cancer treatment and save millions of lives.

 

Selected publications:

  • J. Tang, S. Baxter, A. Menon, et al., Immune cell screening of a nanoparticle library improves atherosclerosis therapy. Proc Natl Acad Sci U S A 113, E6731-E6740 (2016).
  • C. Perez-Medina, D. Abdel-Atti, J. Tang, et al., Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy. Nature communications 7, 11838 (2016).
  • J. Tang, M. E. Lobatto, L. Hassing, et al., Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation. Science advances 1,  (2015).
  • C. Perez-Medina, J. Tang, D. Abdel-Atti, et al., PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles. J Nucl Med 56, 1272-1277 (2015).
  • R. Duivenvoorden*, J. Tang*, D. P. Cormode, et al.,A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation. Nature communications 5, 3065 (2014).
  • Gianella, P. A. Jarzyna, V. Mani, S. Ramachandran, C. Calcagno, J. Tang, et al., Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer. ACS Nano 5, 4422-4433 (2011).